The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10293018" target="_blank" >RIV/00064203:_____/14:10293018 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/14:10293018 RIV/00023761:_____/14:#0000450

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors

Popis výsledku v původním jazyce

OBJECTIVES: To evaluate the significance of plasma adrenomedullin and calcitonin gene-related peptide (CGRP) concentration in patients with Type 2 diabetes mellitus who are treated for hypertension and dyslipidemia. METHOD: Plasma adrenomedullin and CGRPconcentration, transthoracal echocardiography and ABPM were evaluated in 82 patients with Type 2 diabetes mellitus and 41 control subjects with no previous cardiovascular disease. All the subjects had casual blood pressure =140/90 mmHg or received antihypertensive medication, were treated by statin if LDL cholesterol was }= 3mmol/L, by fibrates if triacylglyceroles }= 2 mmol/L. RESULTS: The mean age was 61 +/- 6 in patients with diabetes mellitus and 61 +/- 5 years in control subjects (p=0.9). Plasma CGRP was 3.0 +/- 1.8 in patients with diabetes mellitus and 2.3 +/- 1.0 ng/ml in control subjects (p=0.09). Plasma adrenomedullin was 2.2 +/- 0.9 in patients with diabetes mellitus and 2.8 +/- 1.1 ng/ml in control subjects (p=0.01). In pat

Název v anglickém jazyce

The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors

Popis výsledku anglicky

OBJECTIVES: To evaluate the significance of plasma adrenomedullin and calcitonin gene-related peptide (CGRP) concentration in patients with Type 2 diabetes mellitus who are treated for hypertension and dyslipidemia. METHOD: Plasma adrenomedullin and CGRPconcentration, transthoracal echocardiography and ABPM were evaluated in 82 patients with Type 2 diabetes mellitus and 41 control subjects with no previous cardiovascular disease. All the subjects had casual blood pressure =140/90 mmHg or received antihypertensive medication, were treated by statin if LDL cholesterol was }= 3mmol/L, by fibrates if triacylglyceroles }= 2 mmol/L. RESULTS: The mean age was 61 +/- 6 in patients with diabetes mellitus and 61 +/- 5 years in control subjects (p=0.9). Plasma CGRP was 3.0 +/- 1.8 in patients with diabetes mellitus and 2.3 +/- 1.0 ng/ml in control subjects (p=0.09). Plasma adrenomedullin was 2.2 +/- 0.9 in patients with diabetes mellitus and 2.8 +/- 1.1 ng/ml in control subjects (p=0.01). In pat

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Neuroendocrinology Letters

ISSN

0172-780X

e-ISSN

—

Svazek periodika

35

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

SE - Švédské království

Počet stran výsledku

5

Strana od-do

154-158

Kód UT WoS článku

000340153900012

EID výsledku v databázi Scopus

—